224 related articles for article (PubMed ID: 17308067)
1. Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas.
Senkal CE; Ponnusamy S; Rossi MJ; Bialewski J; Sinha D; Jiang JC; Jazwinski SM; Hannun YA; Ogretmen B
Mol Cancer Ther; 2007 Feb; 6(2):712-22. PubMed ID: 17308067
[TBL] [Abstract][Full Text] [Related]
2. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas.
Koybasi S; Senkal CE; Sundararaj K; Spassieva S; Bielawski J; Osta W; Day TA; Jiang JC; Jazwinski SM; Hannun YA; Obeid LM; Ogretmen B
J Biol Chem; 2004 Oct; 279(43):44311-9. PubMed ID: 15317812
[TBL] [Abstract][Full Text] [Related]
3. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo.
Senkal CE; Ponnusamy S; Rossi MJ; Sundararaj K; Szulc Z; Bielawski J; Bielawska A; Meyer M; Cobanoglu B; Koybasi S; Sinha D; Day TA; Obeid LM; Hannun YA; Ogretmen B
J Pharmacol Exp Ther; 2006 Jun; 317(3):1188-99. PubMed ID: 16510697
[TBL] [Abstract][Full Text] [Related]
4. Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity.
Spassieva S; Seo JG; Jiang JC; Bielawski J; Alvarez-Vasquez F; Jazwinski SM; Hannun YA; Obeid LM
J Biol Chem; 2006 Nov; 281(45):33931-8. PubMed ID: 16951403
[TBL] [Abstract][Full Text] [Related]
5. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.
Senkal CE; Ponnusamy S; Bielawski J; Hannun YA; Ogretmen B
FASEB J; 2010 Jan; 24(1):296-308. PubMed ID: 19723703
[TBL] [Abstract][Full Text] [Related]
6. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C₁₈-ceramide as a novel biomarker for monitoring response.
Saddoughi SA; Garrett-Mayer E; Chaudhary U; O'Brien PE; Afrin LB; Day TA; Gillespie MB; Sharma AK; Wilhoit CS; Bostick R; Senkal CE; Hannun YA; Bielawski J; Simon GR; Shirai K; Ogretmen B
Clin Cancer Res; 2011 Sep; 17(18):6097-105. PubMed ID: 21791630
[TBL] [Abstract][Full Text] [Related]
7. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells.
Baran Y; Salas A; Senkal CE; Gunduz U; Bielawski J; Obeid LM; Ogretmen B
J Biol Chem; 2007 Apr; 282(15):10922-34. PubMed ID: 17303574
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated down-regulation of ceramide synthase 1 leads to apoptotic resistance in human head and neck squamous carcinoma cells after photodynamic therapy.
Separovic D; Breen P; Joseph N; Bielawski J; Pierce JS; VAN Buren E; Gudz TI
Anticancer Res; 2012 Jul; 32(7):2479-2485. PubMed ID: 22753704
[TBL] [Abstract][Full Text] [Related]
9. Increased killing of SCCVII squamous cell carcinoma cells after the combination of Pc 4 photodynamic therapy and dasatinib is associated with enhanced caspase-3 activity and ceramide synthase 1 upregulation.
Separovic D; Breen P; Boppana NB; Van Buren E; Joseph N; Kraveka JM; Rahmaniyan M; Li L; Gudz TI; Bielawska A; Bai A; Bielawski J; Pierce JS; Korbelik M
Int J Oncol; 2013 Dec; 43(6):2064-72. PubMed ID: 24126464
[TBL] [Abstract][Full Text] [Related]
10. (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1.
Min J; Mesika A; Sivaguru M; Van Veldhoven PP; Alexander H; Futerman AH; Alexander S
Mol Cancer Res; 2007 Aug; 5(8):801-12. PubMed ID: 17699106
[TBL] [Abstract][Full Text] [Related]
11. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides.
Mizutani Y; Kihara A; Igarashi Y
Biochem J; 2005 Aug; 390(Pt 1):263-71. PubMed ID: 15823095
[TBL] [Abstract][Full Text] [Related]
12. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network.
Senkal CE; Ponnusamy S; Manevich Y; Meyers-Needham M; Saddoughi SA; Mukhopadyay A; Dent P; Bielawski J; Ogretmen B
J Biol Chem; 2011 Dec; 286(49):42446-42458. PubMed ID: 22013072
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis.
Karahatay S; Thomas K; Koybasi S; Senkal CE; Elojeimy S; Liu X; Bielawski J; Day TA; Gillespie MB; Sinha D; Norris JS; Hannun YA; Ogretmen B
Cancer Lett; 2007 Oct; 256(1):101-11. PubMed ID: 17619081
[TBL] [Abstract][Full Text] [Related]
14. HPV/E7 induces chemotherapy-mediated tumor suppression by ceramide-dependent mitophagy.
Thomas RJ; Oleinik N; Panneer Selvam S; Vaena SG; Dany M; Nganga RN; Depalma R; Baron KD; Kim J; Szulc ZM; Ogretmen B
EMBO Mol Med; 2017 Aug; 9(8):1030-1051. PubMed ID: 28606997
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells.
Rossi MJ; Sundararaj K; Koybasi S; Phillips MS; Szulc ZM; Bielawska A; Day TA; Obeid LM; Hannun YA; Ogretmen B
Otolaryngol Head Neck Surg; 2005 Jan; 132(1):55-62. PubMed ID: 15632910
[TBL] [Abstract][Full Text] [Related]
16. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E succinate induces ceramide-mediated apoptosis in head and neck squamous cell carcinoma in vitro and in vivo.
Gu X; Song X; Dong Y; Cai H; Walters E; Zhang R; Pang X; Xie T; Guo Y; Sridhar R; Califano JA
Clin Cancer Res; 2008 Mar; 14(6):1840-8. PubMed ID: 18347187
[TBL] [Abstract][Full Text] [Related]
18. The CLN9 protein, a regulator of dihydroceramide synthase.
Schulz A; Mousallem T; Venkataramani M; Persaud-Sawin DA; Zucker A; Luberto C; Bielawska A; Bielawski J; Holthuis JC; Jazwinski SM; Kozhaya L; Dbaibo GS; Boustany RM
J Biol Chem; 2006 Feb; 281(5):2784-94. PubMed ID: 16303764
[TBL] [Abstract][Full Text] [Related]
19. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
[TBL] [Abstract][Full Text] [Related]
20. Sp1/Sp3-dependent regulation of human telomerase reverse transcriptase promoter activity by the bioactive sphingolipid ceramide.
Wooten LG; Ogretmen B
J Biol Chem; 2005 Aug; 280(32):28867-76. PubMed ID: 15951564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
